Did you mean?
Search Results - Showing 0 - 12 Of 23
_quizartinib-improves-survival-in-patients-with-flt3-itd-mutated-r-r-aml-quantum-r-trial.jpg "Presented by Mark J. Levis, MD, PhD nnDr. Levis presents results of the QuANTUM-R trial, the first positive phase 3 trial to demonstrate improved OS with single-agent quizartinib in the R/R FLT3-ITD AML setting compared with salvage chemotherapy. The data confirm the safety and efficacy of quizartinib and the value of targeting the FLT3-ITD driver mutation with a highly potent and selective FLT3 inhibitor.")
⏲ 4 min 52 sec ✓ 23-Jul-2018
_what-is-flt3-positive-aml-what-is-gilteritinib-aml.jpg "HealthTree University for Blood Cancers")
⏲ 2 minutes 43 seconds 👁 726
_best-treatment-strategy-for-flt3-itd-aml.jpg "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 2 minutes 20 seconds 👁 566
_quizartinib-for-flt3-itd-positive-aml-after-second-line-chemo-or-stem-cell-transplant.jpg "Research suggests that a new targeted therapy, quizartinib, may be a safe and effective option to treat a subset of patients with treatment-resistant acute myeloid leukaemia (AML), whose leukaemia has the FLT3-ITD mutation.nnQuizartinib is the first and only single-agent drug that has produced a clinical benefit in AML patients with this deadly mutation who have failed previous therapy.nnThe number of patients bridged to a stem cell transplant was very significant. Dr Levis and his colleagues pl")
⏲ 3 min 26 sec ✓ 16-Jan-2018
_significance-of-flt3-mutations-in-aml.jpg "OncLiveTV")
⏲ 4 minutes 30 seconds 👁 189
_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage.jpg "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 2 minutes 54 seconds 👁 155
_quizartinib-advances-overall-survival-in-acute-myeloid-leukaemia-patients.jpg "Dr Harry Erba speaks to ecancer at the EHA 2022 meeting about quizartinib improving the overall survival in adult patients with FLT3-ITD+ acutenmyeloid leukaemia.nn Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults, and approximately 25% of all newly diagnosed cases carry the FLT3-internal tandem duplication (ITD) gene mutation.nnThe results showed that the addition of quizartinib significantly improved overall survival compared with standard induction and consolidation")
⏲ 2 min 14 sec ✓ 11-Jun-2022
_what-is-flt3-mutated-acute-myeloid-leukemia.jpg "Patient Empowerment Network")
⏲ 2 minutes 26 seconds 👁 128
_dr-rllig-on-flt3-itd-npm1-mutation-status-for-patients-with-aml.jpg "Targeted Oncology")
⏲ 2 minutes 9 seconds 👁 654
_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml.jpg "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 1 minute 40 seconds 👁 37
_prognostic-impact-of-flt3-itd-in-older-patients-with-aml.jpg "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 3 minutes 3 seconds 👁 134
_midostaurin-in-c-kit-or-flt3-itd-mutated-t821-aml.jpg "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 3 minutes 42 seconds 👁 355
Related Searches
Search Videos
Recent Searches
_quizartinib-improves-survival-in-patients-with-flt3-itd-mutated-r-r-aml-quantum-r-trial.webp "Presented by Mark J. Levis, MD, PhD nnDr. Levis presents results of the QuANTUM-R trial, the first positive phase 3 trial to demonstrate improved OS with single-agent quizartinib in the R/R FLT3-ITD AML setting compared with salvage chemotherapy. The data confirm the safety and efficacy of quizartinib and the value of targeting the FLT3-ITD driver mutation with a highly potent and selective FLT3 inhibitor.")
_what-is-flt3-positive-aml-what-is-gilteritinib-aml.webp "HealthTree University for Blood Cancers")
_best-treatment-strategy-for-flt3-itd-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_quizartinib-for-flt3-itd-positive-aml-after-second-line-chemo-or-stem-cell-transplant.webp "Research suggests that a new targeted therapy, quizartinib, may be a safe and effective option to treat a subset of patients with treatment-resistant acute myeloid leukaemia (AML), whose leukaemia has the FLT3-ITD mutation.nnQuizartinib is the first and only single-agent drug that has produced a clinical benefit in AML patients with this deadly mutation who have failed previous therapy.nnThe number of patients bridged to a stem cell transplant was very significant. Dr Levis and his colleagues pl")
_significance-of-flt3-mutations-in-aml.webp "OncLiveTV")
_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_quizartinib-advances-overall-survival-in-acute-myeloid-leukaemia-patients.webp "Dr Harry Erba speaks to ecancer at the EHA 2022 meeting about quizartinib improving the overall survival in adult patients with FLT3-ITD+ acutenmyeloid leukaemia.nn Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults, and approximately 25% of all newly diagnosed cases carry the FLT3-internal tandem duplication (ITD) gene mutation.nnThe results showed that the addition of quizartinib significantly improved overall survival compared with standard induction and consolidation")
_what-is-flt3-mutated-acute-myeloid-leukemia.webp "Patient Empowerment Network")
_dr-rllig-on-flt3-itd-npm1-mutation-status-for-patients-with-aml.webp "Targeted Oncology")
_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_prognostic-impact-of-flt3-itd-in-older-patients-with-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_midostaurin-in-c-kit-or-flt3-itd-mutated-t821-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
![[+]](/images/menu.gif){kind=small}